These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7700065)

  • 21. Genetic analysis of cardiovascular risk factor clustering in spontaneous hypertension.
    Pravenec M; Zídek V; Landa V; Kostka V; Musilová A; Kazdová L; Fucíková A; Krenová D; Bíla V; Kren V
    Folia Biol (Praha); 2000; 46(6):233-40. PubMed ID: 11140856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biology and cardiac and vascular changes in hypertension: focus on the renin-angiotensin system].
    Pessina AC; Rossi G
    Ann Ital Med Int; 1994 Oct; 9 Suppl():5S-14S. PubMed ID: 7857757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated and inactivated renin-angiotensin system in transgenic animals: from genes to blood pressure.
    Fukamizu A; Murakami K
    Lab Anim Sci; 1997 Apr; 47(2):127-31. PubMed ID: 9150489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders.
    Merrill DC; Granwehr BP; Davis DR; Sigmund CD
    Proc Assoc Am Physicians; 1997 Nov; 109(6):533-46. PubMed ID: 9394415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.
    Véniant M; Ménard J; Bruneval P; Morley S; Gonzales MF; Mullins J
    J Clin Invest; 1996 Nov; 98(9):1966-70. PubMed ID: 8903314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
    Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
    Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats afer ovariectomy.
    Bachmann J; Wagner J; Haufe C; Wystrychowski A; Ciechanowicz A; Ganten D
    J Hypertens Suppl; 1993 Dec; 11(5):S226-7. PubMed ID: 8158357
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene regulation of beta-1-adrenergic receptor in genetically hypertensive rats.
    Castellano M; Paul M; Beschi M; Bachmann J; Rizzoni D; Porteri E; Bettoni G; Cinelli A; Ganten D; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S64-5. PubMed ID: 8158436
    [No Abstract]   [Full Text] [Related]  

  • 29. Inducible and conditional transgenic mouse models of schizophrenia.
    Pletnikov MV
    Prog Brain Res; 2009; 179():35-47. PubMed ID: 20302816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic aspects of hypertension--etiology of essential hypertension].
    Ogihara T
    Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1172-7. PubMed ID: 7561378
    [No Abstract]   [Full Text] [Related]  

  • 31. The kidney and hypertension: lessons from mouse models.
    Chen D; Coffman TM
    Can J Cardiol; 2012 May; 28(3):305-10. PubMed ID: 22482395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental hypertension. Development of "preventive pathology".
    Yamori Y
    Acta Pathol Jpn; 1982; 32 Suppl 2():359-76. PubMed ID: 7187580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Developmental biotechnology and hypertension--emphasis on renin-angiotensin system].
    Shimada S; Fukamizu A; Murakami K
    Nihon Rinsho; 1993 Jun; 51(6):1562-7. PubMed ID: 8320835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways.
    Lake-Bruse KD; Sigmund CD
    Curr Hypertens Rep; 2000 Apr; 2(2):211-6. PubMed ID: 10981151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic susceptibility to essential hypertension: insight from angiotensinogen.
    Lalouel JM; Rohrwasser A
    Hypertension; 2007 Mar; 49(3):597-603. PubMed ID: 17242300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
    Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of hypertension.
    Kreutz R; Higuchi M; Ganten D
    Clin Exp Hypertens A; 1992; 14(1-2):15-34. PubMed ID: 1541034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat models of cardiovascular diseases.
    Bader M
    Methods Mol Biol; 2010; 597():403-14. PubMed ID: 20013248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of candidate genes for hypertension by fluorescence in situ hybridization on the genome of transgenic rats and mice.
    Schmidt C; Ganten D; Klenk A; Buselmaier W
    Clin Exp Hypertens; 1998 Feb; 20(2):185-204. PubMed ID: 9533613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transcriptional regulation of RAAS genes--in vivo analysis by artificial chromosome transgenic mouse].
    Tanimoto K; Fukamizu A
    Nihon Rinsho; 2012 Sep; 70(9):1466-70. PubMed ID: 23012788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.